Terns Pharmaceuticals Stock Target Price and Analyst Consensus
| TERN Stock | USD 5.79 0.08 1.40% |
The current analyst and expert consensus on Terns Pharmaceuticals is Strong Buy, with 5 strong buy opinions. The current projected Terns Pharmaceuticals target price consensus is 16.63 with 9 analyst opinions. Check out Macroaxis Advice on Terns Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.The most common way Terns Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Terns Pharmaceuticals executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Terns Pharmaceuticals. We strongly encourage you to use your own analysis of Terns Pharmaceuticals to validate this buy or sell advice. Terns Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Terns Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 5.0586.
Lowest Forecast 15.13 | Highest Forecast 18.46 | Target Price 16.63 |
Terns |
It's important to approach Terns Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Terns Pharmaceuticals price targets
Terns Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Terns Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Terns Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Terns Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Terns Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Terns Pharmaceuticals is a key component of Terns Pharmaceuticals valuation and have some predictive power on the future returns of a Terns Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Casinos Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Impulse Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Momentum Invested over 40 shares | |
 | Disruptive Technologies Invested few shares | |
 | Cash Cows Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Chemicals Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Manufacturing Invested over 30 shares | |
 | Hedge Favorites Invested over 60 shares | |
Check out Macroaxis Advice on Terns Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.